Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 70 Women only

3D-printed biodegradable breast implants for breast reconstruction

Official title: A Prospective, Multicenter, Controlled Clinical Study of 3D-printed Biodegradable Breast Implants for Breast Restoration

Run by Xijing Hospital · NCT06993714 · Data updated 2026-11-12

This study is testing if 3D-printed biodegradable breast implants can improve the look and safety of breast reconstruction for women with newly diagnosed breast cancer compared to traditional methods.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 70 Years
SexWomen only
Enrollment120 (estimated)
SponsorXijing Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedMay 1, 2025
Main results expectedJanuary 1, 2028
Study endsDecember 31, 2028
Registry record updatedJune 6, 2025
Trial IDNCT06993714 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are female patients aged 18 to 70 with newly diagnosed primary breast cancer who are eligible for breast-conserving surgery or reconstruction.

Probably not a fit

Patients over 70 years old, those with stage IV metastatic breast cancer, or those with extensive lesions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the cosmetic effects and safety of breast reconstruction using 3D-printed biodegradable material implants in women with newly diagnosed primary breast cancer. Participants will be divided into three groups: one receiving the experimental biodegradable implants, and two control groups undergoing traditional breast-conserving surgery or silicone prosthesis reconstruction. The study aims to compare the quality of life and cosmetic outcomes between these methods. It also assesses the feasibility of using these innovative implants for patients who are not suitable for traditional surgical options.

Why it matters

Potential benefit: If successful, this approach could provide a more personalized and effective option for breast reconstruction, improving cosmetic outcomes and quality of life for patients.

How similar studies have gone: While the use of 3D printing in medical applications is growing, this specific approach to biodegradable breast implants is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients with newly diagnosed primary breast cancer, aged 18 to 70 years, confirmed by histopathology.
* Willing to undergo breast-conserving surgery, concurrent silicone prosthesis breast reconstruction, or breast reconstruction with 3D-printed biodegradable material breast implants.
* Having indications for subcutaneous glandectomy that preserves the nipples and areolas.
* ECOG performance status score: 0-1.
* If receiving neoadjuvant chemotherapy, the interval between chemotherapy completion and surgery is less than 8 weeks.
* Good compliance with the planned treatment, ability to understand the study procedures, and willingness to sign the written informed consent form.

Exclusion Criteria:

* Age \> 70 years.
* Newly diagnosed stage IV metastatic breast cancer.
* Multicentric, extensive, or diffuse lesions; or inflammatory breast cancer.
* Tumor invasion of the papillary areola complex.
* Inability to accept/tolerate radiotherapy.
* Breast cancer during pregnancy.
* History of other malignant tumors within the past five years (except cured cervical carcinoma in situ and non-melanoma skin cancer).
* Abnormal functions of vital organs (heart, lungs, liver, kidneys), poorly controlled diabetes, or other conditions that preclude surgery tolerance.
* Patients deemed unsuitable for participation by the researchers.

Where it's running

  • Xijing hospital
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.